The 6^th Annual Phase I Clinical Trials Conference Day 3: Conference schedule, 16^th June 2005

Time	Stream A
9:00	Registration and coffee
9:30	Opening remarks from the chairs Dr Rashmi Shah Pharmaceutical Industry Consultant, Formerly EMEA Expert Dr Chris Ward Scientific Director, Covance Clinical Research Unit
9:40	Current Status of the “Cocktail” Approach in Early Drug-Drug Interaction Studies Dr Graham Blakey AstraZeneca R&D
10:20	Regulatory Perspective: Presentation of Necessary Drug Interaction Data for Regulatory Submission and Approval Dr Rashmi Shah Pharmaceutical Industry Consultant, Formerly EMEA/MHRA EMEA Rappoteur
11:00	Coffee break
11:30	Drug Drug Interactions during Drug Development: design and methods Dr Alain Patat Director, Clinical Pharmacology, Wyeth Research
12:10	Special Focus on Transporters in DDI Dr Chris Ward Scientific Director, Covance Clinical Research Unit
12:50	Lunch
14:00	Drug-Drug Interactions: Extended Exercise, Presentation and Discussion Session Part I
15:20	Afternoon tea
14:00	Drug-Drug Interactions: Extended Exercise, Presentation and Discussion Session Part II
17:00	Closing remarks from the Chairs and end of day three

You are here:

Links